Stay updated on Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Sign up to get notified when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.

Latest updates to the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page
- Check6 days agoChange DetectedThe page shows a new revision label: Revision: v3.3.2, replacing the previous Revision: v3.2.0. This is a minor metadata update with no changes to the study details or user-facing content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedRemoval of the government funding lapse notice from the NCT01245816 study page on ClinicalTrials.gov.SummaryDifference0.4%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe new page shows minor UI tweaks and small textual edits to non-critical sections; core study information remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check57 days agoChange DetectedUpdate to revision from v3.1.0 to v3.2.0 and add a government funding operating-status notice; remove a specific resource listing (Classic familial adenomatous polyposis).SummaryDifference5%

- Check64 days agoChange Detected- Added Revision: v3.1.0. - Removed several drug-safety/quality topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) indicating a possible scope reduction or reorganization in favor of the new version label.SummaryDifference0.5%

- Check78 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the Back to Top element was removed. This is a small, non-critical update with no changes to core content or key data.SummaryDifference0.3%

Stay in the know with updates to Low Dose Sulindac & Eflornithine for FAP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Sulindac & Eflornithine for FAP Clinical Trial page.